ResMed Inc. (RMD)
NYSE: RMD · IEX Real-Time Price · USD
180.35
+1.50 (0.84%)
Apr 22, 2024, 4:00 PM EDT - Market closed
ResMed Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1996 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 227.89 | 273.71 | 295.28 | 463.16 | 147.13 | 188.7 | 821.94 | 731.43 | 717.25 | 905.73 | Upgrade
|
| Cash & Cash Equivalents | 227.89 | 273.71 | 295.28 | 463.16 | 147.13 | 188.7 | 821.94 | 731.43 | 717.25 | 905.73 | Upgrade
|
| Cash Growth | -16.74% | -7.30% | -36.25% | 214.80% | -22.03% | -77.04% | 12.37% | 1.98% | -20.81% | 3.39% | Upgrade
|
| Receivables | 704.91 | 575.95 | 614.29 | 474.64 | 528.48 | 483.68 | 450.53 | 382.09 | 362.57 | 359.59 | Upgrade
|
| Inventory | 998.01 | 743.91 | 457.03 | 416.92 | 349.64 | 268.7 | 268.32 | 224.46 | 246.86 | 165.42 | Upgrade
|
| Other Current Assets | 437.02 | 337.91 | 208.15 | 168.75 | 120.11 | 124.63 | 103.22 | 81.74 | 81.17 | 125.47 | Upgrade
|
| Total Current Assets | 2,368 | 1,931 | 1,575 | 1,523 | 1,145 | 1,066 | 1,644 | 1,420 | 1,408 | 1,556 | Upgrade
|
| Property, Plant & Equipment | 665.81 | 630.5 | 592.07 | 535.68 | 387.46 | 386.55 | 394.24 | 384.28 | 387.76 | 434.28 | Upgrade
|
| Goodwill and Intangibles | 3,323 | 2,282 | 2,320 | 2,338 | 2,378 | 1,284 | 1,327 | 1,359 | 311.4 | 334.51 | Upgrade
|
| Other Long-Term Assets | 395.43 | 251.49 | 240.82 | 189.74 | 196.46 | 327.53 | 103.57 | 93.66 | 74.77 | 35.97 | Upgrade
|
| Total Long-Term Assets | 4,384 | 3,164 | 3,153 | 3,064 | 2,962 | 1,998 | 1,824 | 1,837 | 773.93 | 804.75 | Upgrade
|
| Total Assets | 6,752 | 5,096 | 4,728 | 4,587 | 4,108 | 3,064 | 3,468 | 3,257 | 2,182 | 2,361 | Upgrade
|
| Accounts Payable | 150.76 | 159.25 | 138.01 | 135.79 | 115.73 | 92.72 | 92.76 | 92.57 | 81.11 | 85.41 | Upgrade
|
| Deferred Revenue | 257.26 | 204.12 | 201.11 | 185.92 | 169.81 | 132.42 | 105.15 | 90.29 | 55.38 | 58.72 | Upgrade
|
| Current Debt | 31.82 | 31.77 | 35.59 | 33.25 | 11.99 | 11.47 | 0 | 299.44 | 0 | 0.02 | Upgrade
|
| Other Current Liabilities | 318.7 | 294.16 | 537.07 | 247.8 | 258.46 | 274.64 | 162.21 | 155.69 | 129.97 | 125.41 | Upgrade
|
| Total Current Liabilities | 758.53 | 689.3 | 911.77 | 602.76 | 555.99 | 511.25 | 360.13 | 637.99 | 266.46 | 269.56 | Upgrade
|
| Long-Term Debt | 1,548 | 885.78 | 758.13 | 1,266 | 1,259 | 269.99 | 1,079 | 873.33 | 300.59 | 300.77 | Upgrade
|
| Other Long-Term Liabilities | 315.19 | 160.03 | 172.55 | 221.58 | 220.64 | 223.71 | 69.48 | 50.55 | 27.41 | 32.39 | Upgrade
|
| Total Long-Term Liabilities | 1,863 | 1,046 | 930.68 | 1,488 | 1,479 | 493.69 | 1,148 | 923.89 | 328 | 333.16 | Upgrade
|
| Total Liabilities | 2,622 | 1,735 | 1,842 | 2,090 | 2,035 | 1,005 | 1,508 | 1,562 | 594.47 | 602.71 | Upgrade
|
| Total Debt | 1,580 | 917.55 | 793.72 | 1,299 | 1,271 | 281.45 | 1,079 | 1,173 | 300.59 | 300.79 | Upgrade
|
| Debt Growth | 72.19% | 15.60% | -38.91% | 2.24% | 351.53% | -73.91% | -8.03% | 290.15% | -0.06% | 0.00% | Upgrade
|
| Retained Earnings | 4,253 | 3,614 | 3,080 | 2,833 | 2,436 | 2,432 | 2,316 | 2,160 | 1,976 | 1,780 | Upgrade
|
| Comprehensive Income | -272.53 | -312.75 | -193.49 | -283.98 | -253.01 | -224.33 | -189.06 | -222.66 | -173.52 | 151.56 | Upgrade
|
| Shareholders' Equity | 4,130 | 3,361 | 2,886 | 2,497 | 2,072 | 2,059 | 1,960 | 1,695 | 1,587 | 1,758 | Upgrade
|
| Net Cash / Debt | -1,352.02 | -643.84 | -498.44 | -836.11 | -1,123.73 | -92.75 | -256.68 | -441.34 | 416.66 | 604.94 | Upgrade
|
| Net Cash / Debt Growth | - | - | - | - | - | - | - | - | -31.12% | 5.16% | Upgrade
|
| Net Cash Per Share | -9.17 | -4.38 | -3.40 | -5.74 | -7.78 | -0.64 | -1.80 | -3.12 | 2.92 | 4.19 | Upgrade
|
| Working Capital | 1,609 | 1,242 | 662.99 | 920.7 | 589.38 | 554.47 | 1,284 | 781.73 | 1,141 | 1,287 | Upgrade
|
| Book Value Per Share | 28.14 | 23.01 | 19.86 | 17.30 | 14.48 | 14.42 | 13.87 | 12.09 | 11.30 | 12.43 | Upgrade
|